Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive approach. Advocates often stress the opportunity for substantial therapeutic outcomes, especially in diseases where conventional therapies have proven ineffective. However, this is to evaluate the considerable financial burden associated with CPI stem cell the